Additional information
Manufacturer |
Merck KGaA |
---|---|
Einecs |
231-545-4 |
Cas-No |
7631-86-9 |
Composition |
Silica |
Quality |
Ph.Eur., USP |
€0.00
Parteck® SLC 500 excipient is part of the Parteck® range of functional excipients developed specifically for solid dose applications. It is an innovative silica drug carrier well-suitable for solubility enhancement of poorly water-soluble active pharmaceutical ingredients. Due to its unique surface structure, it stabilizes the amorphous state of the API.
Low solubility of your active pharmaceutical ingredient (API) is often the cause of poor bioavailability. To improve your formulation we have developed Parteck® SLC, an innovative silica drug carrier that was awarded the silver prize at the 2012 CPhI Pharma Awards. Parteck® SLC provides maximum load for maximum release, significantly increasing bioavailability of your API.
Benefits of Parteck® SLC:
Feasibility studies have proven Parteck® SLC’s outstanding performance both in vitro and in vivo. Parteck® SLC offers the opportunity to reformulate molecules and potentially extend the life cycle of a drug.
Our expert support team is here to help – from early development to production. We offer you feasibility studies on loading your API on the carrier Parteck® SLC, showing the dissolution performance and helping you with final tablet formulation.
Manufacturer |
Merck KGaA |
---|---|
Einecs |
231-545-4 |
Cas-No |
7631-86-9 |
Composition |
Silica |
Quality |
Ph.Eur., USP |